Menu Back toTOPIC-4-SESSION-3-Signal-Management-in-the-European-Union-Industry-Perspective
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Joint MHRA/DIA Excellence in Pharmacovigilance
TOPIC 4 SESSION 3: Signal Management in the European Union: Industry Perspective
Gaby L. Danan, MD, PhD
- Pharmacovigilance Expert
- GLD, France
- Group Manager, Vigilance, Intelligence and Research Group
- Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Signal Management in the European Union: Industry Perspective
- Institute of Pharmacovigilance, Czech Republic